查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614201

基于能量的治疗市场：按产品类型、临床应用和最终用户划分 - 全球预测 2025-2030

Energy-Based Therapeutics Market by Product Type (Cryotherapy, Hydro-Mechanical, Microwave), Clinical Application (Aesthetic, Surgical & Ophthalmic), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年能量疗法市场规模为68亿美元，预计2024年将达72.8亿美元，复合年增长率为7.36%，到2030年将达到111.9亿美元。

以能量为基础的疗法是医疗保健领域一个不断发展的领域，它利用各种形式的能量来治疗医疗状况并提供传统药物疗法的替代治疗方法。该领域包括雷射、射频、超音波和微波等能量，每种能量应用于目标组织以产生治疗效果，例如消融组织、促进癒合以及减轻疼痛和发炎。对基于能量的疗法的需求在于其微创性质，与传统手术方法相比，它通常可以实现更快的恢復时间、更低的感染风险以及更少的疤痕。这些治疗方法应用于广泛的领域，包括皮肤病学、肿瘤学、循环系统和整形外科。最终用途多种多样，包括医院、专科诊所和门诊手术中心。

主要市场统计
基准年[2023] 68亿美元
预计年份 [2024] 72.8亿美元
预测年份 [2030] 111.9亿美元
复合年增长率（%） 7.36%

市场洞察表明，慢性病盛行率上升、技术进步以及消费者对微创手术的需求不断增加是影响该行业成长的关键驱动力。此外，人口老化正在推动需求，因为与老龄化相关的疾病往往需要创新的治疗方法。最新的机会是基于能量的疗法在新兴市场的广泛应用。抓住这些机会的建议包括投资于研究和开发，以扩大能源技术的治疗应用，并扩大策略伙伴关係，以促进进入新兴市场。

然而，市场成长受到高治疗成本、监管障碍以及从业者和患者意识有限的限制。挑战还包括需要严格的临床试验来证明疗效和安全性，这可能会延迟监管核准和市场准入。最佳创新领域包括提高设备的便携性和能源效率，以及开发结合多种能源模式以提高治疗效果的混合系统。随着市场竞争的激烈，企业应专注于持续创新、策略联盟和教育倡议，以克服障碍并利用新趋势。

市场动态：揭示快速发展的能源治疗市场的关键市场洞察

供需的动态交互作用正在改变基于能量的治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 世界各地人口老化不断加剧，癌症等慢性病发生率不断上升。
    • 与传统手术和治疗相比，微波消融系统越来越受欢迎。
  • 市场限制因素
    • 产品召回频率增加
  • 市场机会
    • 基于能量的疗法的创新和发展
    • 能源疗法的政府倡议和有利的报销政策
  • 市场挑战
    • 认识低、缺乏熟练的人力资源和治疗挑战

波特五力：驾驭能源治疗市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对基于能量的治疗市场的外部影响

外部宏观环境因素在塑造能量治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解能量疗法市场的竞争格局

基于能量的治疗市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵能量治疗市场供应商的绩效评估

FPNV定位矩阵是评估能量疗法市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了能源治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，基于能量的治疗市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球老年人口不断增加，癌症等慢性疾病的发生率也正在上升。
      • 微波消融系统比传统手术和治疗更受欢迎
    • 抑制因素
      • 产品召回频率增加
    • 机会
      • 基于能量的疗法的创新和发展
      • 能源疗法的政府措施和有利的报销政策
    • 任务
      • 缺乏意识和熟练人员以及治疗挑战
  • 市场区隔分析
    • 产品类型：越来越多地使用热疗和超音波疗法治疗深部病变
    • 临床应用：采用能量为基础的疗法进行美容应用
    • 最终使用者：能量疗法专科诊所的出现
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章以能量为基础的治疗市场：依产品类型

  • 冷冻疗法
  • 液压机械
  • 微波炉
  • 无线电频率
  • 热和超音波

第七章临床应用的能量治疗市场

  • 美学的
  • 外科/眼科

第八章基于能量的治疗市场：按最终用户分类

  • 诊所
  • 医院

第九章美洲能源治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太能源治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的能量治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Baird Medical 的微波消融系统获得 FDA 510(k) 许可
    • Oculus 推出 IPL、高频治疗设备
    • Emlation 在中东推出快速微波治疗
  • 战略分析和建议

公司名单

  • Alcon Vision LLC
  • Alna-Medicalsystem AG
  • AngioDynamics
  • AtriCure, Inc.
  • BIOLASE, Inc.
  • Biolitec AG
  • Boston Scientific Corporation
  • Bovie Medical Corporation
  • Candela Corporation by Syneron Medical Ltd.
  • Cutera, Inc.
  • Cynosure Inc.
  • Dornier MedTech GmbH
  • EDAP TMS SA
  • Ellex Medical Lasers
  • InSightec Ltd.
  • IRIDEX Corporation
  • Johnson and Johnson Vision Care Inc
  • LightMed Corporation
  • Lumenis Ltd.
  • Medtronic plc
  • NIDEk CO. LTD
  • Optos plc
  • PhotoMedex, Inc.
  • Symmetry Surgical Inc.
  • Ziemer Ophthalmic Systems AG
Product Code: MRR-BB4648AFF39A

The Energy-Based Therapeutics Market was valued at USD 6.80 billion in 2023, expected to reach USD 7.28 billion in 2024, and is projected to grow at a CAGR of 7.36%, to USD 11.19 billion by 2030.

Energy-based therapeutics is an evolving field within healthcare that harnesses various forms of energy to treat medical conditions, offering an alternative to traditional drug-based therapies. The scope of this field includes modalities like laser, radiofrequency, ultrasound, and microwave energy, each applied to target tissues for therapeutic effects such as tissue ablation, promotion of healing, or reduction of pain and inflammation. The necessity of energy-based therapeutics lies in its minimally invasive nature, which often enables quicker recovery times, reduced infection risks, and less scarring compared to traditional surgical techniques. These therapies have broad applications in dermatology, oncology, cardiology, and orthopedics. The end-use scope spans hospitals, specialty clinics, and ambulatory surgical centers.

KEY MARKET STATISTICS
Base Year [2023] USD 6.80 billion
Estimated Year [2024] USD 7.28 billion
Forecast Year [2030] USD 11.19 billion
CAGR (%) 7.36%

Market insights reveal that the rising prevalence of chronic diseases, advancements in technology, and increasing consumer demand for minimally invasive procedures are key drivers influencing growth in this sector. Additionally, demographic shifts towards an aging population fuel demand, as age-related conditions often necessitate innovative treatment methodologies. The latest opportunities involve expanding applications of energy-based therapeutics in emerging markets, driven by increased healthcare spending and improved access to healthcare technology. Recommendations for capturing these opportunities include investing in research and development to broaden the therapeutic indications of energy technologies and expanding strategic partnerships to facilitate market entry in developing regions.

However, market growth faces limitations such as high procedural costs, regulatory barriers, and limited awareness among practitioners and patients. Challenges also include the need for rigorous clinical trials to demonstrate efficacy and safety, which can delay regulatory approvals and market entry. The best areas for innovation include improving device portability and energy efficiency and developing hybrid systems that combine multiple energy modalities for enhanced therapeutic outcomes. As the market nature is highly competitive, businesses should focus on continuous innovation, strategic collaborations, and educational initiatives to overcome barriers and capitalize on emerging trends.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Energy-Based Therapeutics Market

The Energy-Based Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • The increasing geriatric population across the world, coupled with rising incidences of chronic diseases such as cancer
    • The surge in popularity of microwave ablation systems over conventional surgeries and treatment
  • Market Restraints
    • Increasing frequency of product recalls
  • Market Opportunities
    • Technological innovations and developments in energy-based therapeutics
    • Government initiatives and favorable reimbursement policies for energy-based therapeutics
  • Market Challenges
    • The dearth of awareness and skilled manpower and therapeutic challenges

Porter's Five Forces: A Strategic Tool for Navigating the Energy-Based Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Energy-Based Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Energy-Based Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Energy-Based Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Energy-Based Therapeutics Market

A detailed market share analysis in the Energy-Based Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Energy-Based Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Energy-Based Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Energy-Based Therapeutics Market

A strategic analysis of the Energy-Based Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Energy-Based Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Alcon Vision LLC, Alna-Medicalsystem AG, AngioDynamics, AtriCure, Inc., BIOLASE, Inc., Biolitec AG, Boston Scientific Corporation, Bovie Medical Corporation, Candela Corporation by Syneron Medical Ltd., Cutera, Inc., Cynosure Inc., Dornier MedTech GmbH, EDAP TMS S.A., Ellex Medical Lasers, InSightec Ltd., IRIDEX Corporation, Johnson and Johnson Vision Care Inc, LightMed Corporation, Lumenis Ltd., Medtronic plc, NIDEk CO. LTD, Optos plc, PhotoMedex, Inc., Symmetry Surgical Inc., and Ziemer Ophthalmic Systems AG.

Market Segmentation & Coverage

This research report categorizes the Energy-Based Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cryotherapy, Hydro-Mechanical, Microwave, Radiofrequency, and Thermal & Ultrasound.
  • Based on Clinical Application, market is studied across Aesthetic and Surgical & Ophthalmic.
  • Based on End-User, market is studied across Clinics and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. The increasing geriatric population across the world, coupled with rising incidences of chronic diseases such as cancer
      • 5.1.1.2. The surge in popularity of microwave ablation systems over conventional surgeries and treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Increasing frequency of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological innovations and developments in energy-based therapeutics
      • 5.1.3.2. Government initiatives and favorable reimbursement policies for energy-based therapeutics
    • 5.1.4. Challenges
      • 5.1.4.1. The dearth of awareness and skilled manpower and therapeutic challenges
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Growing use of thermal & ultrasound energy-based therapeutics to treat deep-seated lesions
    • 5.2.2. Clinical Application: Adoption of energy-based therapeutics in aesthetic application
    • 5.2.3. End-User: Emergence of a specialized clinic for energy-based therapeutics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Energy-Based Therapeutics Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cryotherapy
  • 6.3. Hydro-Mechanical
  • 6.4. Microwave
  • 6.5. Radiofrequency
  • 6.6. Thermal & Ultrasound

7. Energy-Based Therapeutics Market, by Clinical Application

  • 7.1. Introduction
  • 7.2. Aesthetic
  • 7.3. Surgical & Ophthalmic

8. Energy-Based Therapeutics Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospital

9. Americas Energy-Based Therapeutics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Energy-Based Therapeutics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Energy-Based Therapeutics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Baird Medical's Microwave Ablation System Gains FDA 510(k) Clearance
    • 12.3.2. Oculus launches IPL, Radiofrequency Therapy Devices
    • 12.3.3. Emblation Launches Swift Microwave Therapy in the Middle East
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alcon Vision LLC
  • 2. Alna-Medicalsystem AG
  • 3. AngioDynamics
  • 4. AtriCure, Inc.
  • 5. BIOLASE, Inc.
  • 6. Biolitec AG
  • 7. Boston Scientific Corporation
  • 8. Bovie Medical Corporation
  • 9. Candela Corporation by Syneron Medical Ltd.
  • 10. Cutera, Inc.
  • 11. Cynosure Inc.
  • 12. Dornier MedTech GmbH
  • 13. EDAP TMS S.A.
  • 14. Ellex Medical Lasers
  • 15. InSightec Ltd.
  • 16. IRIDEX Corporation
  • 17. Johnson and Johnson Vision Care Inc
  • 18. LightMed Corporation
  • 19. Lumenis Ltd.
  • 20. Medtronic plc
  • 21. NIDEk CO. LTD
  • 22. Optos plc
  • 23. PhotoMedex, Inc.
  • 24. Symmetry Surgical Inc.
  • 25. Ziemer Ophthalmic Systems AG

LIST OF FIGURES

  • FIGURE 1. ENERGY-BASED THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. ENERGY-BASED THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ENERGY-BASED THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ENERGY-BASED THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENERGY-BASED THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ENERGY-BASED THERAPEUTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CRYOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY HYDRO-MECHANICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY MICROWAVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY THERMAL & ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY AESTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY SURGICAL & OPHTHALMIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. ENERGY-BASED THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. ENERGY-BASED THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023